Tocladesine in Treating Patients With Recurrent or Refractory Multiple Myeloma

Clinical trial NCT00004902 · COMPLETED

Trial details

NCT number: NCT00004902
Sponsor: Northwestern University
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple Myeloma and Plasma Cell Neoplasm

Start date: 1998-01-01
Primary completion: 1999-11-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.